Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Barth

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
Current Pharmaceutical Design|August 20, 2009
Recombinant immunotoxins--the next generationStefan Barth
Current Pharmaceutical Design|February 26, 2013
The SNAP-tag technology - a versatile tool with many applicationsStefan Barth
Current Opinion in Molecular Therapeutics|March 9, 2002
Technology evaluation: BL22, NCIStefan Barth
Immunotherapy Advances|November 21, 2022
TIM-3: a tumor-associated antigen beyond checkpoint inhibition?Stefan Barth, Krupa Naran
Molecular Biotechnology|January 29, 2025
AAV Capsid Modification and Its Influence on Viral Protein Stoichiometry and Packaging Fitness: Current Understandings and Future DirectionDennis Makafui Dogbey, Stefan Barth
Biomedicines|September 23, 2022
The Potential of Antibody Technology and Silver Nanoparticles for Enhancing Photodynamic Therapy for MelanomaZaria Malindi, Stefan Barth, Heidi Abrahamse
Molecular Diagnosis & Therapy|February 7, 2017
SNAP-Tag Technology: A Promising Tool for Ex Vivo ImmunophenotypingSwati Choudhary, Stefan Barth, Rama S Verma
Current Pharmaceutical Design|February 26, 2013
SNAP-tag technology: a powerful tool for site specific conjugation of therapeutic and imaging agentsAhmad Fawzi Hussain, Manal Amoury, Stefan Barth
Frontiers in Microbiology|January 10, 2019
Principles of Immunotherapy: Implications for Treatment Strategies in Cancer and Infectious DiseasesKrupa Naran, Trishana Nundalall, Shivan Chetty, et al.
Immunopharmacology and Immunotoxicology|May 16, 2025
<i>In vitro</i> anti-tumor activities of a novel recombinant immunotoxin targeting differentially overexpressed Leucine-rich repeat-containing G-protein-coupled receptor 5 in cervical cancerMarc Henry, Takunda Ngwegya, Nkhasi Lekena, et al.
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Current Pharmaceutical Design|August 20, 2009
Recombinant immunotoxins--the next generationStefan Barth
Current Pharmaceutical Design|February 26, 2013
The SNAP-tag technology - a versatile tool with many applicationsStefan Barth
Current Opinion in Molecular Therapeutics|March 9, 2002
Technology evaluation: BL22, NCIStefan Barth
Immunotherapy Advances|November 21, 2022
TIM-3: a tumor-associated antigen beyond checkpoint inhibition?Stefan Barth, Krupa Naran
Molecular Biotechnology|January 29, 2025
AAV Capsid Modification and Its Influence on Viral Protein Stoichiometry and Packaging Fitness: Current Understandings and Future DirectionDennis Makafui Dogbey, Stefan Barth
Biomedicines|September 23, 2022
The Potential of Antibody Technology and Silver Nanoparticles for Enhancing Photodynamic Therapy for MelanomaZaria Malindi, Stefan Barth, Heidi Abrahamse
Molecular Diagnosis & Therapy|February 7, 2017
SNAP-Tag Technology: A Promising Tool for Ex Vivo ImmunophenotypingSwati Choudhary, Stefan Barth, Rama S Verma
Current Pharmaceutical Design|February 26, 2013
SNAP-tag technology: a powerful tool for site specific conjugation of therapeutic and imaging agentsAhmad Fawzi Hussain, Manal Amoury, Stefan Barth
Frontiers in Microbiology|January 10, 2019
Principles of Immunotherapy: Implications for Treatment Strategies in Cancer and Infectious DiseasesKrupa Naran, Trishana Nundalall, Shivan Chetty, et al.
Immunopharmacology and Immunotoxicology|May 16, 2025
<i>In vitro</i> anti-tumor activities of a novel recombinant immunotoxin targeting differentially overexpressed Leucine-rich repeat-containing G-protein-coupled receptor 5 in cervical cancerMarc Henry, Takunda Ngwegya, Nkhasi Lekena, et al.
Pageof 15